Cargando…
KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer
Autores principales: | Tsoi, Ho, Man, Ellen PS, Leung, Man‐Hong, Mok, Ka‐Chun, Chau, Ka‐Man, Wong, Lai‐San, Chan, Wing‐Lok, Chan, Sum‐Yin, Luk, Mai‐Yee, Cheng, Cheuk‐Nam, Khoo, Ui‐Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506633/ https://www.ncbi.nlm.nih.gov/pubmed/34709749 http://dx.doi.org/10.1002/ctm2.554 |
Ejemplares similares
-
SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2023) -
A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2
por: Leung, Man-Hong, et al.
Publicado: (2020) -
Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2022) -
Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2021) -
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2022)